Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDK | P21741 | 4/20 | 0.36 |
| ▸ | BDNF | P23560 | 3/20 | 0.36 |
| ▸ | PTN | P21246 | 2/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.34 |
| ▸ | CD69 | Q07108 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.32 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.32 |
| ▸ | SI | P14410 | 2/20 | 0.32 |
| ▸ | STAT3 | P40763 | 3/20 | 0.32 |
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25445487 | 1.00 | MDK (0.36) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL16521135 | 0.86 | LGALS3 (0.35) | LGALS3LGALS8LGALS4CD69MAPK1 | |
| SCHEMBL17521207 | 0.82 | BDNF (0.37) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL15082697 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL4544701 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL15215584 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL25121361 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL12213976 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL21374694 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL12085239 | 0.81 | MAPK1 (0.44) | MDKBDNFPTNLGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9446136-B2 | Modified hyaluronic acid polymer compositions and related methods | CARBYLAN THERAPEUTICS, INC. (US) | 2016-09-20 | — | — | US | disclosed |